5 research outputs found
NMR and in silico studies of fucosylated chondroitin sulfate (fCS) and its interactions with selectins
This thesis describes structural studies on the interactions between the fucosylated
chondroitin sulfate (fCS) oligosaccharides and human proteins known as selectins. fCS is a
carbohydrate obtained from sea cucumbers, that can be classified as a branched
glycosaminoglycan (GAG). It has attracted much attention due to its anti-coagulant, anti-inflammatory,
antimetastatic and anti-HIV properties and its structure was previously
determined by NMR. Selectins constitute a family of proteins involved in cell adhesion
processes, such as inflammation, attachment of viral particles and migration of tumour cells.
fCS oligosaccharides have been shown to bind to selectins, which is likely a reason behind
their biological activity. However, the mechanism of this interaction is currently unknown.
The initial part of the thesis describes the experimental work on expression and purification
of the recombinant L- and P-selectin constructs in Pichia pastoris, Escherichia coli and HEK
293 cells. The aim of these experiments was to produce two constructs for each selectin, a
single domain construct, consisting of the C-type lectin domain only, and a double domain
construct, consisting of both the C-type lectin and the EGF-like domains. The intention was
that the recombinant proteins would be labelled with 13C and 15N to allow for the in-depth
structural NMR studies on the fCS-selectin interaction. Various experimental approaches
have been explored, including the use of different cell lines, modifications to construct design,
as well as alterations to expression and purification conditions. Although it was not possible
to produce soluble selectin constructs in either bacterial or yeast cells, protein expression
tests in HEK293 cells, performed in collaboration with the Oxford Protein Production facility
(OPPF), led to production of a soluble L-selectin construct, consisting of the L-selectin C-type
lectin domain.
The produced L-selectin construct, as well as two commercially available constructs of the Land
P-selectin extracellular domains, were used in the Saturation Transfer Difference (STD)
NMR experiments to provide new information about the nature of the fCS-selectin binding.
The STD experiments allowed to identify the regions within the fCS oligosaccharides that are
in direct contact with the protein and likely play an important role in this interaction.
Experiments on different protein constructs allowed the comparison of fCS binding to P-selectin
and to two different recombinant constructs of L-selectin. Results of these studies
suggest that the binding occurs via a similar mechanism for both L- and P-selectins and that
the fCS oligosaccharides bind to one-domain L-selectin construct with similar affinity as to a
larger construct, consisting of the entire extracellular region of the protein.
Alongside the experimental work, theoretical in silico studies on the fCS-selectin binding
were undertaken as part of this project. The existing X-ray structures of selectin complexes
were subjected to Molecular Dynamics (MD) simulations, which allowed to explore the
dynamic behaviour of E-selectin upon binding to sialyl Lewis x (sLex). It was found that sLex
forms a more favourable interaction with the extended conformation of E-selectin and that
the protein in this conformation is characterised by a high degree of interdomain flexibility,
with a new type of interdomain movement observed in the MD studies on this complex.
In further in silico studies, the fCS oligosaccharides were docked to the existing P-selectin
structures. The docking tests were performed on the computationally produced fCS
trisaccharides with fucose branches either 2,4 or 3,4-sulfated. Results were evaluated with
MD simulations and analysed in the light of current knowledge of selectin-ligand binding and
the STD NMR experimental results. The in silico studies allowed to identify a subset of P-selectin
residues that are likely involved in the interaction with fCS oligosaccharides in vivo.
The conformational behaviour of P-selectin upon binding to fCS was also explored and it was
found that the interdomain hinge is flexible during this interaction and allows transition from
bent to extended conformational state.
Finally, a new NMR method was developed to facilitate the studies of complex carbohydrates,
incorporating the concepts of G-matrix Fourier Transform (GFT) NMR into 2D HSQC and 2D
HSQC-TOCSY experiments. The method allows to separate peaks in the regions of high
spectral overlap, providing information that can simplify the assignment process. The new
experiments facilitated the structural evaluation of a sample containing a mixture of
oligosaccharides resulting from the depolymerisation of fCS polysaccharide
Biodegradable Chitosan Decreases the Immune Response to Trichinella spiralis in Mice
The purpose of this study was to evaluate the potential of chitosan units released during natural degradation of the polymer to activate the immune system against T. spiralis infection. High molecular weight chitosan was injected intraperitoneally into C57BL/6 mice. Flow cytometry and cytokine concentration, measured by ELISA, were used to characterize peritoneal cell populations during T. spiralis infection. The strong chemo-attractive properties of chitosan caused considerable infiltration into the peritoneal cavity of CD11b+ cells, with reduced expression of MHC class II, CD80, CD86, Dectin-1 or CD23 receptors in comparison to T. spiralis-infected mice. After prolonged chitosan biodegradation, cell populations expressing IL-4R, MR and Dectin-1 receptors were found to coexist with elevated IL-6, IL-10, TGF-β and IgA production. IgA cross-reacted with T. spiralis antigen and chitosan. It was found that chitosan treatment attracted immune cells with low activity, which resulted in the number of nematodes increasing. The glucosamine and N-acetyl-D-glucosamine residues were recognized by wheat germ agglutinin (WGA) lectin and therefore any biodegradable chitosan units may actively downregulate the immune response to the parasite. The findings are relevant for both people and animals treated with chitosan preparations
Effectiveness of Hyperbaric Oxygen Therapy in SARS-CoV-2 Pneumonia: The Primary Results of a Randomised Clinical Trial
Mortality in COVID-19 is mainly associated with respiratory failure, cytokine storm, and macrophage activation. Oxygenation and anti-inflammatory effects of Hyperbaric Oxygen Therapy (HBOT) suggest that it is a promising adjunct treatment for COVID-19. Repeated sessions of HBO with standard COVID-19 therapy were used to reduce the inflammation and increase oxygenation. We evaluated the safety and efficacy of HBOT in avoiding the replacement ventilation and/or ECMO and its effect on the inflammatory process. Twenty-eight moderate-to-severe COVID-19 patients were randomized into control or HBOT group. HBOT patients participated in 5 hyperbaric sessions (60 min). Before and after each session blood gas levels and vital parameters were monitored. Blood samples were collected for extended biochemical tests, blood morphology and immunological assays. There were 3 deaths in the control, no deaths in the HBOT group. No adverse events leading to discontinuation of HBOT were observed and patients receiving HBOT required lower oxygen delivery. We observed decrease in CRP, ferritin and LDH and increase in CD3 in HBOT group compared to control. This study confirmed the feasibility and safety of HBOT in patients with COVID-19 and indicated HBOT can lead to alleviation of inflammation and partial restoration of T cell responses
Effect of Hyperbaric Oxygenation on Blood Cytokines and Arginine Derivatives; No Evidence for Induction of Inflammation or Endothelial Injury
(1) Background: Hyperbaric oxygen therapy (HBOT) uses 100% oxygen delivered at 1.5-3 times the atmospheric pressure in a specialised chamber to achieve supraphysiological oxygen tension in blood and tissues. Besides its target, HBOT may affect inflammation, endothelial function or angiogenesis. This study analysed the effect of HBOT on blood concentrations of factors that may affect these processes in patients with necrotizing soft-tissue infections (NSTI), aseptic bone necrosis (ABN) and idiopathic sudden sensory neural hearing loss (ISSNHL). (2) Methods: Concentrations asymmetric dimethylarginine (ADMA) and other arginine derivatives were measured with liquid chromatography/mass spectrometry, whereas ELISA was used to quantitate vascular endothelial growth factor (VEGF) and cytokines (IL-1, IL-4, IL-6, IL-10, TGF-beta) before and after HBOT in 80 patients (NSTI n = 21, ISSNHL n = 53, ABN n = 6). (3) Results: While some differences were noted between patient groups in ADMA and other arginine derivatives as well as in cytokine concentrations, HBOT did not affect any of these parameters. (4) Conclusions: While cytokines and arginine derivatives concentrations were modified by underlying pathology, hyperbaric oxygenation did not immediately modify it suggesting that it is neutral for inflammation and is not inducing endothelial injury
Effect of Hyperbaric Oxygenation on Blood Cytokines and Arginine Derivatives; No Evidence for Induction of Inflammation or Endothelial Injury
(1) Background: Hyperbaric oxygen therapy (HBOT) uses 100% oxygen delivered at 1.5–3 times the atmospheric pressure in a specialised chamber to achieve supraphysiological oxygen tension in blood and tissues. Besides its target, HBOT may affect inflammation, endothelial function or angiogenesis. This study analysed the effect of HBOT on blood concentrations of factors that may affect these processes in patients with necrotizing soft-tissue infections (NSTI), aseptic bone necrosis (ABN) and idiopathic sudden sensory neural hearing loss (ISSNHL). (2) Methods: Concentrations asymmetric dimethylarginine (ADMA) and other arginine derivatives were measured with liquid chromatography/mass spectrometry, whereas ELISA was used to quantitate vascular endothelial growth factor (VEGF) and cytokines (IL-1, IL-4, IL-6, IL-10, TGF-β) before and after HBOT in 80 patients (NSTI n = 21, ISSNHL n = 53, ABN n = 6). (3) Results: While some differences were noted between patient groups in ADMA and other arginine derivatives as well as in cytokine concentrations, HBOT did not affect any of these parameters. (4) Conclusions: While cytokines and arginine derivatives concentrations were modified by underlying pathology, hyperbaric oxygenation did not immediately modify it suggesting that it is neutral for inflammation and is not inducing endothelial injury